{
  "metadata": {
    "title": "Associations between diffusion MRI microstructure and cerebrospinal fluid markers of Alzheimers disease pathology and neurodegeneration along the Alzheimers disease continuum",
    "authors": [
      "Jason F Moody",
      "Douglas C Dean",
      "Steve R Kecskemeti",
      "Kaj Blennow",
      "Henrik Zetterberg",
      "Gwendlyn Kollmorgen",
      "Ivonne Suridjan",
      "Norbert Wild",
      "Cynthia M Carlsson",
      "Sterling C Johnson",
      "Andrew L Alexander",
      "Barbara B Bendlin",
      "Wisconsin Alzheimer'"
    ],
    "abstract": "Introduction: White matter (WM) degeneration is a critical component of early Alzheimers disease (AD) pathophysiology. Diffusion-weighted imaging (DWI) models, including diffusion tensor imaging (DTI), neurite orientation dispersion and density imaging (NODDI), and mean apparent propagator MRI (MAP-MRI), have the potential to identify early neurodegenerative WM changes associated with AD. Methods: We imaged 213 (198 cognitively unimpaired) aging adults with DWI and used tract-based spatial statistics to compare 15 DWI metrics of WM microstructure to 9 cerebrospinal fluid (CSF) markers of AD pathology and neurodegeneration treated as continuous variables.",
    "publication_date": ""
  },
  "content": {
    "INTRODUCTION": {
      "text": "Degeneration of subcortical white matter (WM) is increasingly recognized as a critical process of early Alzheimers disease (AD) pathophysiology, with some studies suggesting that WM degeneration may precede cortical atrophy. 12345 Given that neurodegeneration is closely associated with cognitive dysfunction in AD, the discovery and development of reliable and sensitive in-vivo markers for neurodegeneration are important goals of AD research, as these prospective measures may aid in the identification of cognitively unimpaired individuals who are at risk for developing AD in the future, as well as provide crucial information pertaining to the staging and progression of AD. 6 WM changes are commonly studied using diffusion-weighted imaging (DWI), a modality that operates by sensitizing the magnetic resonance imaging (MRI) signal to the diffusion of water molecules in the brain. The most prevalent DWI model used to study WM changes associated with AD is diffusion tensor imaging (DTI). 6 While DTI studies of AD have been informative, the model has known limitations, including providing limited information in regions with greater restricted (non-Gaussian) diffusion, such as that present within cellular structures. 7,8 An increasingly popular alternative to DTI applied in contemporary AD research is neurite orientation density and dispersion imaging (NODDI). 9 NODDI is a biophysically-based model which characterizes brain changes in specific microstructural environments by assuming that the DWI signal emanates from 3 distinct tissue compartments:\nwithin neurites, outside of neurites, and free water. 9 The primary NODDI measures are the neurite density index (NDI -the signal fraction from within neurites), the orientation dispersion index (ODI -the degree of angular variation among neurites), and the isotropic volume fraction (ISO -the signal fraction from a free water compartment).\nNODDI has shown promise for evaluating neurodegeneration along the clinical continuum of AD, 101112 as well as alterations along the biological spectrum of AD pathology. 13 An alternative DWI model with minimal assumptions about tissue microstructure is mean apparent propagator (MAP) MRI. 14,15 In MAP-MRI, the probability density function describing the displacements of diffusing water molecules is estimated directly from the DWI signal.\nMAP-MRI measures include the return to origin probability (RTOP), the return to axis probability (RTAP), the return to plane probability (RTPP), the mean squared displacement (MSD), the Non-Gaussianity (NG), and the q-space inverse variance (QIV). 14,15 RTOP quantifies the probability that a proton will remain in the same relative position in 3D space between 2 consecutive diffusion gradient pulses, and therefore, is a marker for tissue restriction. RTAP and RTPP are the 2D and 1D counterparts of RTOP and are sensitive to restrictive barriers perpendicular and parallel to the principal direction of diffusion, respectively.\nNG, which can similarly be decomposed into components that are perpendicular (NG  ) and parallel (NG  ) to the principal direction of diffusion, represents the fraction of the DWI signal that does not conform to a Gaussian distribution, and therefore, serves as a barometer for complex tissue organization. MSD, another indicator of tissue restriction, is a measure of how far diffusing water molecules travel between successive diffusion gradient pulses. Finally, QIV is a measure of the variance in the diffusion signal. 141516 Recently, MAP-MRI has been shown to be more useful than DTI for the evaluation of Parkinsons disease severity 17 as well as temporal lobe epilepsy lateralization. 18 Additionally, 1 study found evidence that MAP-MRI was sensitive to age-dependent amyloid burden in transgenic Alzheimer rats (TgF344-AD), 19 paving the way for future studies to explore the potential of MAP-MRI to identify AD-related microstructural changes in humans.\nIn order to investigate WM microstructural alterations associated with AD across the brain, we applied DTI, NODDI, and for the very first",
      "subsections": {}
    },
    "Participant selection": {
      "text": "We identified 213 participants ( S1.",
      "subsections": {}
    },
    "CSF biomarker acquisition and designation of amyloid and tau pathology status": {
      "text": "All DWI images were corrected for noise, 27 Gibbs ringing, 27 and eddy current-induced distortions 282930 and 5-shell images were corrected for susceptibility-induced distortions. 31 Diffusion tensors were estimated in each voxel with weighted least squares regression using b values 1500 smm 2 (i.e., the 2 inner shells) and DTI parameter maps (FA, MD, RD, AxD) were computed. The NODDI model was implemented via the Diffusion Microstructure Imaging in Python toolbox, 32 using d   1.7 ùúám2ms, to calculate NDI, ODI, and ISO parameter maps.",
      "subsections": {}
    },
    "MAP-MRI was applied to the diffusion data with Diffusion Imaging in": {
      "text": "Python software, 33 which fit the DWI signal to Hermite basis functions using a radial order of 6 and regularized the corresponding basis coefficients with the Laplacian of the reconstructed signal. 16 The regularized basis coefficients were utilized to calculate parameter maps of RTOP, RTAP, RTPP, MSD, NG, NG  , NG  , and QIV (Figure S1).",
      "subsections": {}
    },
    "Tract-based spatial statistics (TBSS) processing": {
      "text": "In order to evaluate the relationship between all diffusion metrics and CSF biomarkers across WM regions, diffusion parameter maps were processed with the TBSS pipeline. 34 FA maps for all 213 participants were registered to MNI 152 1 mm 3 space with nonlinear registration. 30 The resultant warps were used to register the other 14 diffusion parameter maps into the same space. The FA maps in MNI space were used to estimate a population mean FA (WM) skeleton via a cutoff FA value of 0.2, and all other DWI metrics were projected onto this skeleton so that statistical analysis could be performed.",
      "subsections": {}
    },
    "Data harmonization": {
      "text": "Prior to statistical testing, all diffusion data were harmonized across scanner (scanner 1 vs. scanner 2) and diffusion protocol (3 shell vs. 5 shell) using neuroHarmonize software in Python. 35,36 Neuro-Harmonize allows for the application of the Combat algorithm, a well-established technique that was first introduced to remove batcheffects in genomics, 37 directly to the harmonization of quantitative brain imaging data. Age and sex were specified as linear covariates, so that only the effects of scanner and diffusion protocol were minimized during the harmonization process.",
      "subsections": {}
    },
    "Linear modeling and statistics": {
      "text": "Each imaging voxel was fit to the following general linear model (GLM) using Randomise 38 :\nThis model is linear with respect to CSF biomarker (continuous variable) and incudes age (continuous variable) and sex (categorical variable) as covariates. All data were demeaned, and threshold-free cluster enhancement 39 was utilized to identify clusters of WM skeleton voxels that exhibited significant associations between diffusion parameters and CSF biomarkers after nonparametric permutation testing (with 5000 permutations), correcting for multiple comparisons across voxels (P corr  0.05). In order to preserve statistical power, no corrections for multiple comparisons were made across DWI-CSF associations.\nThe percentage of WM skeleton voxels exhibiting significant associations between diffusion parameters and CSF biomarkers were computed for each DWI-CSF marker pair along with corresponding effect sizes (Cohens f2). Binary masks of these voxels were created and combined to: (1)",
      "subsections": {}
    },
    "Supplementary analyses": {
      "text": "We performed 4 supplementary analyses:",
      "subsections": {}
    },
    "Widespread associations with markers of AD pathology and axonal degeneration": {
      "text": "Overall, there were widespread significant relationships between diffusion metrics of WM microstructure and CSF markers for amyloid plaques, phosphorylated tau proteins, and axonal degeneration across the brain (Figures 123, Table 2 Note: That the associations between each DWI-CSF marker pair were always in the same direction across WM voxels. of WM skeleton voxels. Of the 9 total associations between diffusion microstructural parameters and NfL, QIV and RTPP were the most prevalent, with 83.1 and 80.6 of WM skeleton voxels related for each metric, respectively (Table 2). Most of the significant DWI-CSF relationships persisted in separate analyses of the 3-shell and 5-shell data (Tables S5-S6) and 21 different DWI-CSF marker pairs exhibited significant associations when analysis was restricted to 198 preclinical participants (Table S3).\nWhen the 2 inner shells of DWI data were used to fit diffusion tensors to each imaging voxel (all b values 1500 smm 2 ), no DTI metrics had significant relationships with AŒ≤ 4240 , pTau, pTau AŒ≤ 42 , or NfL that survived corrections for age, sex, and multiple comparisons across voxels (Table 2). However, when incorporating an extra shell into the DTI model, RD, MD, and AxD were all positively associated with NfL, while MD and RD were positively related to pTauAŒ≤ 42 (Table S4).\nWM regions with the largest number of total diffusion parameters associated with CSF markers included the CING, CC, and SLF (Figure 1). Conversely, areas with the fewest number were primarily concentrated in the brainstem and peripheral brain regions.\nPartial correlations between select CSF markers and DWI metrics extracted from the CC, CING, and SLF ranged from weak to moderate (Figures S2-S5).\nF I G U R E 3 WM skeleton voxels (highlighted using the TBSS_fill command) with significant associations between CSF markers (top panel: pTauAŒ≤ 42 , bottom panel: NfL) and DWI metrics (MAP-MRI: rbed, NODDI: blue, DTI: none) overlaid on the 1 mm MNI 152 standard T1 template. WM is delineated by the mean FA skeleton of all subjects (green). Results are corrected for age, sex, and multiple comparisons across voxels with p  0.05.",
      "subsections": {}
    },
    "MAP-MRI and sensitivity to amyloid and tau pathology": {
      "text": "A comparison of DWI techniques revealed that MAP-MRI metrics had particularly widespread associations with AŒ≤ 4240 and pTau and larger corresponding effect sizes, compared with NODDI and DTI metrics (Figure 2, Table 2, Table S2). With respect to AŒ≤ 4240 , 3 of the 4 diffusion indices that had significant associations with this amyloid biomarker were MAP-MRI metrics (RTOP, NG, and NG  ), with RTOP being the most prevalent. Comparably, of the 6-diffusion metrics meaningfully related to pTau, 4 were MAP-MRI metrics (RTPP, NG, NG  , QIV), with NG  having the most robust relationship to pTau (Table 2). Despite differing sensitivities to AŒ≤ 4240 and pTau levels, MAP-MRI and NODDI performed similarly in being able to detect changes in pTauAŒ≤ 42 across the brain (Figure 3).",
      "subsections": {}
    },
    "Associations with markers of synaptic degeneration, glial activation, and inflammation": {
      "text": "Notable associations between DWI metrics and sTREM2, GFAP, and Œ±-synuclein were also observed. There were 5 diffusion metrics with a meaningful relationship to sTREM2 (Positive: MD, RD, AxD; Negative: NG, NG  ), 4 to GFAP (Positive: FA, NDI; Negative: ISO, MSD), and 2 to Œ±-synuclein (Negative: NG, NG  ). These included particularly large associations between NG  and Œ±-synuclein (in 35.5 of WM skeleton voxels) and sTREM2 (in 49.6 of WM skeleton voxels) as well as between NDI and GFAP (in 60.6 of WM skeleton voxels). Lastly, there were zero significant associations between any diffusion parameter and YKL-40 or neurogranin (Table 2).",
      "subsections": {}
    },
    "DISCUSSION": {
      "text": "While MRI investigations of neurodegeneration in AD have most commonly focused on gross macrostructural brain changes, such as reduced cortical volume and thickness, there is now considerable evidence to suggest that neurodegeneration can be captured with techniques sensitive to tissue microstructure along the AD continuum even prior to cortical atrophy. 13 Furthermore, studies have shown that degenerative WM microstructural changes, including axonal degeneration, demyelination, inflammation, and alterations in cellularity, are involved in AD and methods that measure these phenomena provide useful and complementary information related to the onset and progression of AD pathology. In this study, we used 3 distinct DWI techniques to identify widespread relationships between CSF markers of AD and DWI markers of WM degeneration along the AD continuum, which may suggest that little subcortical WM is spared from the effects of AD. to pTau (NG, NG  ). While the associations were much less extensive across the WM skeleton voxels of the brain, there remained 8 different DWI indices that had some significant sensitivity to CSF markers of AD pathology or neurodegeneration, among our preclinical cohort. Notably, the diffusion imaging sequences applied in this study can be acquired in under 10 min, 42 making the derivation of these metrics a clinically viable tool for early detection of AD-related neurodegeneration.",
      "subsections": {}
    },
    "MAP-MRI and NODDI may be sensitive to microstructural signatures of AD-related neurodegeneration": {
      "text": "In our study, MAP-MRI outperformed NODDI and DTI in detecting changes in CSF biomarkers of AD pathology and neurodegeneration across the WM fiber bundles of the brain. This may be a consequence of the fact that MAP-MRI metrics more directly relate to the microstructural features of brain tissue and characterize non-Gaussian diffusion profiles indicative of more complex tissue organization. Therefore, these markers may be especially sensitive to common neurodegenerative changes, including those central to AD pathology, such as axonal degeneration, demyelination, inflammation, and reductions in tissue cellularity.\nFor example, water diffusion is highly restricted within axons, dendrites, and cellular membranes and organelles, resulting in non-Gaussian diffusion. Decreased Non-Gaussianity (NG) from MAP-MRI suggests reduced tissue complexity and is likely a sensitive marker of axonal loss and demyelination, 15 which are 2 hallmark features of ADrelated WM degeneration. 43,44 NfL, which was predictive of NG, NG  , and NG  in our sample, is sensitive to both. 45,46 Moreover, NG  had a strikingly widespread association with Œ±-synuclein, a presynaptic protein and known marker for synaptic degeneration. 22 In this context, it is likely that damaged synapses (in the cortices) are concurrently affecting nearby (subcortical) WM and that NG  , by detecting subtle increases in diffusion Gaussianity in the affected area, is sensitive to this damage. Additionally, higher AŒ≤ 4240 levels in our sample were predictive of widespread increases in RTOP, suggesting that amyloid accumulation in AD is associated with pervasive reductions in tissue restriction.\nFurthermore, MAP-MRI and NODDI metrics exhibited widespread associations with pTauAŒ≤ 42 , and NfL. Notably, increases in both markers were predictive of extensive reductions in NDI, suggesting that reduced neurite density may be a characteristic feature of early AD pathology. These relationships pervaded association, commissural, projection and brainstem fiber bundles, spanning every lobule of the brain. While several studies of WM hyperintensities in AD have focused on frontal and temporal regions associated with memory and executive function, 474849 our results suggest that WM changes in early pre-symptomatic stagers of AD progression might be more widespread than is commonly appreciated. It is possible that the microstructural WM changes detected by DWI indices in this study are happening on a whole brain scale, in parallel with well-documented global atrophy of WM and gray matter structures.",
      "subsections": {}
    },
    "Limitations": {
      "text": "A few limitations should be noted. First, we are limited by our crosssectional study design. Ideally, we would have multiple CSF biomarker measurements and DWIs per participant, so that we could better account for individual variability in brain structure and age-related changes to both CSF and DWI markers. Second, some caution should be used when interpreting DWI indices and CSF biomarkers. For example, a change in RTOP may be dictated by changes in cellularity, myelination, and axonal volume. 14,15,50,51 Without corroborating histological studies, it can be difficult to attribute specific DWI measurements to specific tissue properties. Similarly, in a mostly preclinical cohort, pTau does not directly reflect the regional accumulation of neurofibrillary tangles and is probably, at least in part, indicative of a neuronal response to the deposition of Œ≤-amyloid proteins. 13,52 As a result, it is likely that some of our DWI associations with pTau are artificially inflated by underlying amyloid pathology. Third, we did not consider the presence of WM hyperintensities (WMH) in our analysis. Because previous studies have shown that DTI 53 and NODDI 54 metrics are associated with the presence of WMH and because the majority of individuals over the age of 60 exhibit WMH, 53 we cannot rule out the possibility that some of our results may be influenced by uneven macrostructural WM damage between participants. Last, while data harmonization reduces the variability between DWI protocols, it cannot entirely remove protocol-dependent differences in sensitivity to tissue properties. Because of this, we assessed the associations between DWI metrics and CSF markers in the 3shell and 5-shell cohorts independently, finding evidence that some of these relationships appear to be robust to differences in acquisition parameters.",
      "subsections": {}
    }
  }
}